{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:01:19Z","timestamp":1792598479685,"version":"4.5.0"},"reference-count":78,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T00:00:00Z","timestamp":1604448000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,2,19]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>BACKGROUND<\/jats:title>\n                  <jats:p>Mild ovarian stimulation has emerged as an alternative to conventional IVF with the advantages of being more patient-friendly and less expensive. Inadequate data on pregnancy outcomes and concerns about the cycle cancellation rate (CCR) have prevented mild, or low-dose, IVF from gaining wide acceptance.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>OBJECTIVE AND RATIONALE<\/jats:title>\n                  <jats:p>To evaluate parallel-group randomised controlled trials (RCTs) on IVF where comparisons were made between a mild (\u2264150 IU daily dose) and conventional stimulation in terms of clinical outcomes and cost-effectiveness in patients described as poor, normal and non-polycystic ovary syndrome (PCOS) hyper-responders to IVF.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>SEARCH METHODS<\/jats:title>\n                  <jats:p>Searches with no language restrictions were performed using Medline, Embase, Cochrane central, Pre-Medicine from January 1990 until April 2020, using pre-specified search terms. References of included studies were hand-searched as well as advance access articles to key journals. Only parallel-group RCTs that used \u2264150 IU daily dose of gonadotrophin as mild-dose IVF (MD-IVF) and compared with a higher conventional dose (CD-IVF) were included. Studies were grouped under poor, normal or hyper-responders as described by the authors in their inclusion criteria. Women with PCOS were excluded in the hyper-responder group. The risk of bias was assessed as per Cochrane Handbook for the included studies. The quality of evidence (QoE) was assessed according to the GRADE system. PRISMA guidance was followed for review methodology.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>OUTCOMES<\/jats:title>\n                  <jats:p>A total of 31 RCTs were included in the analysis: 15 in the poor, 14 in the normal and 2 in the hyper-responder group. Live birth rates (LBRs) per randomisation were similar following use of MD-IVF in poor (relative risk (RR) 0.91 (CI 0.68, 1.22)), normal (RR 0.88 (CI 0.69, 1.12)) and hyper-responders (RR 0.98 (CI 0.79, 1.22)) when compared to CD-IVF. QoE was moderate. Cumulative LBRs (5 RCTs, n\u2009=\u20092037) also were similar in all three patient types (RR 0.96 (CI 0.86 1.07) (moderate QoE). Risk of ovarian hyperstimulation syndrome was significantly less with MD-IVF than CD-IVF in both normal (RR 0.22 (CI 0.10, 0.50)) and hyper-responders (RR 0.47 (CI 0.31, 0.72)), with moderate QoE. The CCRs were comparable in poor (RR 1.33 (CI 0.96, 1.85)) and hyper-responders (RR 1.31 (CI 0.98, 1.77)) but increased with MD-IVF among normal responders (RR 2.08 (CI 1.38, 3.14)); all low to very low QoE. Although fewer oocytes were retrieved and fewer embryos created with MD-IVF, the proportion of high-grade embryos was similar in all three population types (low QoE). Compared to CD-IVF, MD-IVF was associated with less gonadotrophin use and lower cost.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>WIDER IMPLICATIONS<\/jats:title>\n                  <jats:p>This updated review provides reassurance on using MD-IVF not only for the LBR per cycle but also for the cumulative LBR, with moderate QoE. With risks identified with \u2018freeze-all\u2019 strategies, it may be time to recommend mild-dose ovarian stimulation for IVF for all categories of women i.e. hyper, poor and normal responders to IVF.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/humupd\/dmaa035","type":"journal-article","created":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T11:29:29Z","timestamp":1596194969000},"page":"229-253","source":"Crossref","is-referenced-by-count":91,"title":["Mild versus conventional ovarian stimulation for IVF in poor, normal and hyper-responders: a systematic review and meta-analysis"],"prefix":"10.1093","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3764-9298","authenticated-orcid":false,"given":"Adrija Kumar","family":"Datta","sequence":"first","affiliation":[{"name":"Create Fertility, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3652-2447","authenticated-orcid":false,"given":"Abha","family":"Maheshwari","sequence":"additional","affiliation":[{"name":"Aberdeen Fertility Centre and NHS Grampian, Aberdeen, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirmal","family":"Felix","sequence":"additional","affiliation":[{"name":"Create Fertility, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Campbell","sequence":"additional","affiliation":[{"name":"St George\u2019s University of London, London, UK"},{"name":"Create Fertility, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geeta","family":"Nargund","sequence":"additional","affiliation":[{"name":"Create Fertility, London, UK"},{"name":"St Georges University Hospitals NHS Trust London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,11,4]]},"reference":[{"key":"2021022406581457100_dmaa035-B1","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.fertnstert.2014.08.013","article-title":"Ovarian response to recombinant human follicle-stimulating hormone: a randomized, antimullerian hormone-stratified, dose-response trial in women undergoing in vitro fertilization\/intracytoplasmic sperm injection","volume":"102","author":"Arce","year":"2014","journal-title":"Fertil Steril"},{"key":"2021022406581457100_dmaa035-B2","first-page":"593","article-title":"Evaluation of ovulation induction protocols for poor responders undergoing assisted reproduction techniques","volume":"26","author":"Ashrafi","year":"2005","journal-title":"Saudi Med J"},{"key":"2021022406581457100_dmaa035-B3","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1093\/humrep\/del484","article-title":"Milder ovarian stimulation for in-vitro fertilization reduces aneuploidy in the human preimplantation embryo: a randomized controlled trial","volume":"22","author":"Baart","year":"2007","journal-title":"Hum Reprod"},{"key":"2021022406581457100_dmaa035-B4","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ejogrb.2016.05.027","article-title":"A randomized, single-blind, prospective trial comparing three different gonadotropin doses with or without addition of letrozole during ovulation stimulation in patients with poor ovarian response","volume":"203","author":"Bastu","year":"2016","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2021022406581457100_dmaa035-B5","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/uog.17442","article-title":"Clomiphene citrate and letrozole to reduce follicle-stimulating hormone consumption during ovarian stimulation: systematic review and meta-analysis","volume":"50","author":"Bechtejew","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2021022406581457100_dmaa035-B6","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1210\/jc.2010-2239","article-title":"Follicular phase endocrine characteristics during ovarian stimulation and GnRH antagonist cotreatment for IVF: RCT comparing recFSH initiated on cycle day 2 or 5","volume":"96","author":"Blockeel","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2021022406581457100_dmaa035-B7","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1007\/s10815-012-9863-2","article-title":"MILD ovarian stimulation with GnRH-antagonist vs. long protocol with low dose FSH for non-PCO high responders undergoing IVF: A prospective, randomized study including thawing cycles","volume":"29","author":"Casano","year":"2012","journal-title":"J Assist Reprod Genet"},{"key":"2021022406581457100_dmaa035-B8","first-page":"225","author":"Datta","year":"2020"},{"key":"2021022406581457100_dmaa035-B9","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1093\/humrep\/dem171","article-title":"The psychological impact of IVF failure after two or more cycles of IVF with a mild versus standard treatment strategy","volume":"22","author":"de Klerk","year":"2007","journal-title":"Hum Reprod"},{"key":"2021022406581457100_dmaa035-B10","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1093\/oxfordjournals.humrep.a136039","article-title":"Prospective randomized study of clomiphene citrate and gonadotrophins versus goserelin and gonadotrophins for follicular stimulation in assisted reproduction","volume":"10","author":"Dhont","year":"1995","journal-title":"Hum Reprod"},{"key":"2021022406581457100_dmaa035-B11","first-page":"370","article-title":"Conventional ovarian stimulation and single embryo transfer for IVF\/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?","volume":"31","author":"Drakopoulos","year":"2016","journal-title":"Hum Reprod"},{"key":"2021022406581457100_dmaa035-B23668624","first-page":"101","article-title":"Letrozole+ GnRH antagonist stimulation protocol in poor ovarian responders undergoing intracytoplasmic sperm injection cycles: an RCT","author":"Ebrahimi","year":"2017","journal-title":"IJRM"},{"key":"2021022406581457100_dmaa035-B30946378","first-page":"725","article-title":"Comparison of pregnancy outcome after letrozoleversus clomiphene treatment for mild ovarian stimulation protocol in poor responders","author":"Eftekhar","year":"2014","journal-title":"Iranian Journal Ofreproductive Medicine"},{"key":"2021022406581457100_dmaa035-B12","doi-asserted-by":"crossref","first-page":"e194","DOI":"10.1016\/j.fertnstert.2016.07.565","article-title":"Low cost ovarian stimulation protocolis associated with lower pregnancy rate in normal responders in comparison to long protocol","volume":"106","author":"Elnashar","year":"2016","journal-title":"Fertil Steril"},{"key":"2021022406581457100_dmaa035-B13","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1080\/09513590.2017.1320385","article-title":"Effectiveness of mild ovarian stimulation versus GnRH agonist protocol in women undergoing assisted reproductive technology: a meta-analysis","volume":"33","author":"Fan","year":"2017","journal-title":"Gynecol Endocrinol"},{"key":"2021022406581457100_dmaa035-B14","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1093\/humrep\/der092","article-title":"ESHRE consensus on the definition of \u2018poor response\u2019 to ovarian stimulation for in vitro fertilization: the Bologna criteria","volume":"26","author":"Ferraretti","year":"2011","journal-title":"Hum Reprod"},{"key":"2021022406581457100_dmaa035-B15","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s00404-012-2672-0","article-title":"Clomiphene combined with gonadotropins and GnRH antagonist versus conventional controlled ovarian hyperstimulation without clomiphene in women undergoing assisted reproductive techniques: systematic review and meta-analysis","volume":"287","author":"Figueiredo","year":"2013","journal-title":"Arch Gynecol Obstet"},{"key":"2021022406581457100_dmaa035-B45119614","doi-asserted-by":"publisher","first-page":"e65","DOI":"10.1016\/j.fertnstert.2014.07.224","article-title":"Efficacy of clomiphene citrate supplementation to\u00a0conventional GnRH antagonist protocols in\u00a0poor responders undergoing assisted reproductive technology- a prospective randomized trial","author":"Fujimoto","year":"2014","journal-title":"Fertility and Sterility"},{"key":"2021022406581457100_dmaa035-B16","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3109\/19396368.2015.1089607","article-title":"The continuum of high ovarian response: a rational approach to the management of high responder patient subgroups","volume":"61","author":"Gat","year":"2015","journal-title":"Syst Biol Reprod Med"},{"key":"2021022406581457100_dmaa035-B152","first-page":"i316","article-title":"Improved ICSI outcome in poor responders using a novel stimulation regime with micro-dose flare followed by GnRH antagonist in mid follicular phase","volume":"25(Suppl 1)","author":"Ghoshdastidar","year":"2010","journal-title":"Human Reproduction"},{"key":"2021022406581457100_dmaa035-B17","first-page":"CD008528","article-title":"Clomiphene citrate in combination with gonadotropins for controlled ovarian stimulation in women undergoing in vitro fertilization","volume":"11","author":"Gibreel","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"2021022406581457100_dmaa035-B18","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1093\/humrep\/deh359","article-title":"A randomized single-blind controlled trial of letrozole as a low-cost IVF protocol in women with poor ovarian response: a preliminary report","volume":"19","author":"Goswami","year":"2004","journal-title":"Hum Reprod"},{"key":"2021022406581457100_dmaa035-B97589350","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3109\/09513599909167571","article-title":"Good results of milder form of ovarian stimulation in an in vitro fertilization\/intracytoplasmic sperm injection program","author":"Grochowski","year":"1999","journal-title":"Gynecological Endocrinology"},{"key":"2021022406581457100_dmaa035-B19","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S0015-0282(16)56947-7","article-title":"Should gonadotropin-releasing hormone down-regulation therapy be routine in in vitro fertilization?","volume":"62","author":"Harrison","year":"1994","journal-title":"Fertil Steril"},{"key":"2021022406581457100_dmaa035-B20","first-page":"i141","author":"Heijnen","year":"2020"},{"key":"2021022406581457100_dmaa035-B21","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0140-6736(07)60360-2","article-title":"A mild treatment strategy for in-vitro fertilisation: a randomised non-inferiority trial.[Reprint in Ned Tijdschr Geneeskd. 2008 Apr 5;152(14):809-16; PMID: 18491824]","volume":"369","author":"Heijnen","year":"2007","journal-title":"Lancet"},{"key":"2021022406581457100_dmaa035-B22","author":"Higgins","year":"2011"},{"key":"2021022406581457100_dmaa035-B23","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1210\/jc.2002-020788","article-title":"A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol","volume":"88","author":"Hohmann","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2021022406581457100_dmaa035-B24","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1093\/humrep\/16.7.1391","article-title":"Friendly IVF: patient opinions","volume":"16","author":"Hojgaard","year":"2001","journal-title":"Hum Reprod"},{"key":"2021022406581457100_dmaa035-B8802020","first-page":"470","volume":"19"},{"key":"2021022406581457100_dmaa035-B25","first-page":"i49","article-title":"The comparison of mild stimulation vs. Controlled ovarian hyperstimulation protocol in poor ovarian responders: a prospective randomized study","volume":"1","author":"Huang","year":"2015","journal-title":"Hum Reprod"},{"key":"2021022406581457100_dmaa035-B1821441","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/j.1471-0528.2010.02545.x","article-title":"A randomised controlled trial of 300 versus 225\u2003IU recombinant FSH for ovarian stimulation in predicted normal responders by antral follicle count","author":"Jayaprakasan","year":"2010","journal-title":"BJOG: An International Journal of Obstetrics & Gynaecology"},{"key":"2021022406581457100_dmaa035-B33960143","doi-asserted-by":"publisher","first-page":"S273","DOI":"10.1016\/j.fertnstert.2013.07.1137","article-title":"A prospective randomised controlled study comparing a low-cost antagonist protocol using oral ovulation inducing agents in IVF-ICSI cycles with a standard agonist long protocol","author":"Jindal","year":"2013","journal-title":"Fertility and Sterility"},{"key":"2021022406581457100_dmaa035-B26","first-page":"CD008528","article-title":"Oral medications including clomiphene citrate or aromatase inhibitors with gonadotropins for controlled ovarian stimulation in women undergoing in vitro fertilisation","volume":"11","author":"Kamath","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"2021022406581457100_dmaa035-B27","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s00404-009-1252-4","article-title":"Comparison of mild stimulation and conventional stimulation in ART outcome","volume":"281","author":"Karimzadeh","year":"2010","journal-title":"Arch Gynecol Obstet"},{"key":"2021022406581457100_dmaa035-B28","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/j.fertnstert.2009.06.005","article-title":"Minimal stimulation using gonadotropin-releasing hormone (GnRH) antagonist and recombinant human follicle-stimulating hormone versus GnRH antagonist multiple-dose protocol in low responders undergoing in vitro fertilization\/intracytoplasmic sperm injection","volume":"92","author":"Kim","year":"2009","journal-title":"Fertil Steril"},{"key":"2021022406581457100_dmaa035-B498723","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S0015-0282(16)54962-0","article-title":"The routine use of gonadotropin-releasing hormone agonists for all patients undergoing in vitro fertilization. Is there any medical advantage? A prospective randomized study","author":"Kingsland","year":"1992","journal-title":"Fertility and Sterility"},{"key":"2021022406581457100_dmaa035-B29","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/humrep\/deh663","article-title":"Expected poor responders on the basis of an antral follicle count do not benefit from a higher starting dose of gonadotrophins in IVF treatment: a randomized controlled trial","volume":"20","author":"Klinkert","year":"2005","journal-title":"Hum Reprod"},{"key":"2021022406581457100_dmaa035-B5642525","first-page":"70","article-title":"Will letrozole improve the ovarian response and live-birth rate in women with poor ovarian reserve who are undergoing in-vitro fertilisation treatment? A randomised controlled trial","author":"Lee","year":"2011","journal-title":"Human Fertility"},{"key":"2021022406581457100_dmaa035-B30","first-page":"1954","author":"Leijdekkers","year":"2019"},{"key":"2021022406581457100_dmaa035-B31","first-page":"CD012693","article-title":"Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF\/ICSI)","volume":"2","author":"Lensen","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"2021022406581457100_dmaa035-B32","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/09513590600702733","article-title":"Comparison of outcome of clomiphene citrate\/human menopausal gonadotropin\/cetrorelix protocol and buserelin long protocol\u2014a randomized study","volume":"22","author":"Lin","year":"2006","journal-title":"Gynecol Endocrinol"},{"key":"2021022406581457100_dmaa035-B33","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1007\/s00404-020-05513-6","article-title":"Mild stimulation protocol vs conventional controlled ovarian stimulation protocol in poor ovarian response patients: a prospective randomized controlled trial","volume":"301","author":"Liu","year":"2020","journal-title":"Arch Gynecol Obstet"},{"key":"2021022406581457100_dmaa035-B62479601","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0015-0282(16)57795-4","article-title":"Luteal phase consequences of low-dose gonadotropin-releasing hormone agonist therapy in nonluteal-supported in vitro fertilization cycles**Supported in part by the Vicksburg Hospital Medical Foundation, Vicksburg, Mississippi","author":"Long","year":"1995","journal-title":"Fertility and Sterility"},{"key":"2021022406581457100_dmaa035-B34","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1177\/147323001003800622","article-title":"Modified natural cycle for in vitro fertilization and embryo transfer in normal ovarian responders","volume":"38","author":"Lou","year":"2010","journal-title":"J Int Med Res"},{"key":"2021022406581457100_dmaa035-B35","first-page":"355","article-title":"Comparison of \"short protocol\" versus \"antagosnits\" with or without clomiphene citrate for stimulation in IVF of patients with \"low response\" [Spanish]","volume":"20","author":"Martinez","year":"2003","journal-title":"Rev Iberoam Fertil Reprod Hum"},{"key":"2021022406581457100_dmaa035-B36","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1159\/000355980","article-title":"Mild ovarian stimulation for in vitro fertilization: are we ready to change? A meta-analysis","volume":"76","author":"Matsaseng","year":"2013","journal-title":"Gynecol Obstet Invest"},{"key":"2021022406581457100_dmaa035-B37","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3109\/09513590.2012.730569","article-title":"Minimal stimulation protocol using letrozole versus microdose flare up GnRH agonist protocol in women with poor ovarian response undergoing ICSI","volume":"29","author":"Mohsen","year":"2013","journal-title":"Gynecol Endocrinol"},{"key":"2021022406581457100_dmaa035-B38","doi-asserted-by":"crossref","first-page":"170","DOI":"10.4103\/0974-1208.101014","article-title":"Letrozole in a low-cost in vitro fertilization protocol in intracytoplasmic sperm injection cycles for male factor infertility: a randomized controlled trial","volume":"5","author":"Mukherjee","year":"2012","journal-title":"J Hum Reprod Sci"},{"key":"2021022406581457100_dmaa035-B7387768","doi-asserted-by":"publisher","first-page":"166","DOI":"10.5539\/gjhs.v8n4p166","article-title":"Comparison of GnRh Agonist Microdose Flare Up and GnRh Antagonist\/Letrozole in Treatment of Poor Responder Patients in Intra Cytoplaspic Sperm Injection: Randomized Clinical Trial","author":"Nabati","year":"2015","journal-title":"GJHS"},{"key":"2021022406581457100_dmaa035-B39","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.fertnstert.2017.08.022","article-title":"Mild stimulation for in vitro fertilization","volume":"108","author":"Nargund","year":"2017","journal-title":"Fertil Steril"},{"key":"2021022406581457100_dmaa035-B40","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1093\/humrep\/dem285","article-title":"The ISMAAR proposal on terminology for ovarian stimulation for IVF","volume":"22","author":"Nargund","year":"2007","journal-title":"Hum Reprod"},{"key":"2021022406581457100_dmaa035-B41","author":"Nargund","year":"2020"},{"key":"2021022406581457100_dmaa035-B42","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1093\/humrep\/dex319","article-title":"Individualized versus standard FSH dosing in women starting IVF\/ICSI: an RCT. Part 2: the predicted hyper responder","volume":"32","author":"Oudshoorn","year":"2017","journal-title":"Hum Reprod"},{"key":"2021022406581457100_dmaa035-B43","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/humrep\/deh044","article-title":"A randomized, double-blind, multicentre clinical trial comparing starting doses of 150 and 200 IU of recombinant FSH in women treated with the GnRH antagonist ganirelix for assisted reproduction","volume":"19","author":"Out","year":"2004","journal-title":"Hum Reprod"},{"key":"2021022406581457100_dmaa035-B8413525","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3109\/09513590.2014.893571","article-title":"The comparision of effect of microdose GnRH-a flare-up, GnRH antagonist\/aromatase inhibitor letrozole and GnRH antagonist\/clomiphene citrate protocols on IVF outcomes in poor responder patients","author":"Ozcan Cenksoy","year":"2014","journal-title":"Gynecological Endocrinology"},{"key":"2021022406581457100_dmaa035-B44","first-page":"35","article-title":"Comparison pregnancy outcomes between minimal stimulation protocol and conventional GnRH antagonist protocols in poor ovarian responders","volume":"10","author":"Pilehvari","year":"2016","journal-title":"J Family Reprod Health"},{"key":"2021022406581457100_dmaa035-B9850786","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1093\/humrep\/deg472","article-title":"A prospective randomized clinical trial comparing an individual dose of recombinant FSH based on predictive factors versus a'standard' dose of 150 IU\/day in'standard' patients undergoing IVF\/ICSI treatment","author":"Popovic-Todorovic","year":"2003","journal-title":"Human Reproduction"},{"key":"2021022406581457100_dmaa035-B45","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.fertnstert.2018.03.019","article-title":"Comparison of pregnancy rates for poor responders using IVF with mild ovarian stimulation versus conventional IVF: a guideline","volume":"109","year":"2018","journal-title":"Fertil Steril"},{"key":"2021022406581457100_dmaa035-B8461685","first-page":"1151","article-title":"Comparison of two different fixed doses of follitropin-beta in controlled ovarian hyperstimulation: A prospective randomized, double blind clinical trial","author":"Pruksananonda","year":"2004","journal-title":"J Med Assoc Thai"},{"key":"2021022406581457100_dmaa035-B46","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/1477-7827-10-114","article-title":"Clomiphene citrate versus high doses of gonadotropins for in vitro fertilisation in women with compromised ovarian reserve: a randomised controlled non-inferiority trial","volume":"10","author":"Ragni","year":"2012","journal-title":"Reprod Biol Endocrinol"},{"key":"2021022406581457100_dmaa035-B47","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s10815-014-0227-y","article-title":"\"Mild\" vs. \"long\" protocol for controlled ovarian hyperstimulation in patients with expected poor ovarian responsiveness undergoing in vitro fertilization (IVF): a large prospective randomized trial","volume":"31","author":"Revelli","year":"2014","journal-title":"J Assist Reprod Genet"},{"key":"2021022406581457100_dmaa035-B48","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/humupd\/dmy033","article-title":"Fresh versus elective frozen embryo transfer in IVF\/ICSI cycles: a systematic review and meta-analysis of reproductive outcomes","volume":"25","author":"Roque","year":"2019","journal-title":"Hum Reprod Update"},{"key":"2021022406581457100_dmaa035-B0961180","first-page":"4354","article-title":"Short gonadotropin-releasing hormone agonist versus flexible antagonist versus clomiphene citrate regimens in poor responders undergoing in vitro fertilization: a randomized controlled trial","author":"Schimberni","year":"2016","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2021022406581457100_dmaa035-B8007996","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2147\/IJWH.S117577","article-title":"Effectiveness of corifollitropin alfa used for ovarian stimulation of poor responder patients","author":"Selman","year":"2016","journal-title":"IJWH"},{"key":"2021022406581457100_dmaa035-B4403740","first-page":"i438","article-title":"Mild versus conventional ovarian stimulation for poor responders undergoing IVF\/ICSI: A prospective randomized study. Human Reproduction","volume":"31","author":"Siristatidis","year":"2016"},{"key":"2021022406581457100_dmaa035-B49","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejogrb.2016.07.498","article-title":"Efficiency of mild ovarian stimulation with clomiphene on poor ovarian responders during IVF\\ICSI procedures: a meta-analysis","volume":"204","author":"Song","year":"2016","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2021022406581457100_dmaa035-B50","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/humupd\/dmq041","article-title":"Clinical outcomes in relation to the daily dose of recombinant follicle-stimulating hormone for ovarian stimulation in in vitro fertilization in presumed normal responders younger than 39 years: a meta-analysis","volume":"17","author":"Sterrenburg","year":"2011","journal-title":"Hum Reprod Update"},{"key":"2021022406581457100_dmaa035-B51","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s10815-005-1497-1","article-title":"A randomized, double-blind, multicenter study comparing a starting dose of 100 IU or 200 IU of recombinant follicle stimulating hormone (Puregon) in women undergoing controlled ovarian hyperstimulation for IVF treatment","volume":"22","author":"Tan","year":"2005","journal-title":"J Assist Reprod Genet"},{"key":"2021022406581457100_dmaa035-B52","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0015-0282(16)55264-9","article-title":"Randomized, prospective comparison of luteal leuprolide acetate and gonadotropins versus clomiphene citrate and gonadotropins in 408 first cycles of in vitro fertilization","volume":"58","author":"Tummon","year":"1992","journal-title":"Fertil Steril"},{"key":"2021022406581457100_dmaa035-B53","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1093\/humrep\/dex318","article-title":"Individualized versus standard FSH dosing in women starting IVF\/ICSI: an RCT. Part 1: the predicted poor responder","volume":"32","author":"van Tilborg","year":"2017","journal-title":"Hum Reprod"},{"key":"2021022406581457100_dmaa035-B68350221","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0015-0282(02)03174-6","article-title":"Comparison of stimulation with clomiphene citrate in combination with recombinant follicle-stimulating hormone and recombinant luteinizing hormone to stimulation with a gonadotropin-releasing hormone agonist protocol: a prospective, randomized study","author":"Weigert","year":"2002","journal-title":"Fertility and Sterility"},{"key":"2021022406581457100_dmaa035-B2988365","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1093\/humrep\/16.8.1676","article-title":"A prospective, randomized comparison of two starting doses of recombinant FSH in combination with cetrorelix in women undergoing ovarian stimulation for IVF\/ICSI","author":"Wikland","year":"2001","journal-title":"Human Reproduction"},{"key":"2021022406581457100_dmaa035-B54","first-page":"112","article-title":"A mild ovarian stimulation strategy in women with poor ovarian reserve undergoing IVF: a multicenter randomized non-inferiority trial","volume":"32","author":"Youssef","year":"2017","journal-title":"Hum Reprod"},{"key":"2021022406581457100_dmaa035-B55","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.fertnstert.2017.10.033","article-title":"Low dosing of gonadotropins in in vitro fertilization cycles for women with poor ovarian reserve: systematic review and meta-analysis","volume":"109","author":"Youssef","year":"2018","journal-title":"Fertil Steril"},{"key":"2021022406581457100_dmaa035-B56","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1177\/0300060518770346","article-title":"Comparison of modified agonist, mild-stimulation and antagonist protocols for in vitro fertilization in patients with diminished ovarian reserve","volume":"46","author":"Yu","year":"2018","journal-title":"J Int Med Res"},{"key":"2021022406581457100_dmaa035-B57","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1093\/humrep\/dep343","article-title":"International Committee for Monitoring Assisted Reproductive Technology, World Health Organization. The International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) revised glossary on ART terminology, 2009","volume":"24","author":"Zegers-Hochschild","year":"2009","journal-title":"Hum Reprod"},{"key":"2021022406581457100_dmaa035-B151","doi-asserted-by":"crossref","first-page":"96.e91","DOI":"10.1016\/j.ajog.2015.08.009","article-title":"Minimal stimulation IVF vs conventional IVF: A randomized controlled trial","volume":"214","author":"Zhang","year":"2016","journal-title":"American Journal of Obstetrics and Gynecology"}],"container-title":["Human Reproduction Update"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/humupd\/article-pdf\/27\/2\/229\/36325457\/dmaa035.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/humupd\/article-pdf\/27\/2\/229\/36325457\/dmaa035.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T06:59:26Z","timestamp":1614149966000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humupd\/article\/27\/2\/229\/5955862"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,4]]},"references-count":78,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,11,4]]},"published-print":{"date-parts":[[2021,2,19]]}},"URL":"https:\/\/doi.org\/10.1093\/humupd\/dmaa035","relation":{},"ISSN":["1355-4786","1460-2369"],"issn-type":[{"value":"1355-4786","type":"print"},{"value":"1460-2369","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,3,1]]},"published":{"date-parts":[[2020,11,4]]}}}